Almirall and BioFocus cement partnership
This article was originally published in Scrip
Executive Summary
Almirall of Spain has built on its existing relationship with Galapagos subsidiary BioFocus by signing a three-year research collaboration aimed at delivering "drug development candidates directed to a key respiratory target of interest to Almirall".